Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Daniel Kelly

Showing results (71-80 of 140) with videos related to

Pageof 14
Sort By:
PLOS Global Public Health|January 27, 2026
Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in LiberiaMoses Badio, Meekie Glayweon, Collin Van Ryn, et al.
The Journal of Clinical Investigation|December 17, 2024
Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypesTasha Tsao, Amanda M Buck, Lilian Grimbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
Neurological, Cognitive, and Psychological Findings Among Survivors of Ebola Virus Disease From the 1995 Ebola Outbreak in Kikwit, Democratic Republic of Congo: A Cross-sectional StudyJ Daniel Kelly, Nicole A Hoff, D'Andre Spencer, et al.
MMWR. Morbidity and Mortality Weekly Report|September 8, 2022
Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022Michel Tassetto, Miguel Garcia-Knight, Khamal Anglin, et al.
Ophthalmology Science|June 19, 2026
Pediatric Ebola Eye Disease in the PREVAIL (Partnership for Research on Ebola Virus in Liberia) III Longitudinal Cohort StudyRhea Kulkarni, Nii Quartey-Papafio, Jemma Larbelee, et al.
Plos Neglected Tropical Diseases|May 18, 2022
Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of CongoAnna Bratcher, Nicole A Hoff, Reena H Doshi, et al.
Epidemics|August 10, 2019
Real-time predictions of the 2018-2019 Ebola virus disease outbreak in the Democratic Republic of the Congo using Hawkes point process modelsJ Daniel Kelly, Junhyung Park, Ryan J Harrigan, et al.
The Journal of Infectious Diseases|January 12, 2018
Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16J Daniel Kelly, Mohamed Bailor Barrie, Annelies W Mesman, et al.
Plos Neglected Tropical Diseases|November 16, 2016
Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional SerosurveyEugene T Richardson, J Daniel Kelly, Mohamed Bailor Barrie, et al.
Plos Neglected Tropical Diseases|August 12, 2021
Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of CongoAnna Bratcher, Nicole A Hoff, Reena H Doshi, et al.
Pageof 14

Showing results (71-80 of 140) with videos related to

Sort By:
Pageof 14
PLOS Global Public Health|January 27, 2026
Long-term psychosocial sequelae of Ebola virus disease among survivors compared with contacts following the 2013-2016 epidemic in LiberiaMoses Badio, Meekie Glayweon, Collin Van Ryn, et al.
The Journal of Clinical Investigation|December 17, 2024
Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypesTasha Tsao, Amanda M Buck, Lilian Grimbert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
Neurological, Cognitive, and Psychological Findings Among Survivors of Ebola Virus Disease From the 1995 Ebola Outbreak in Kikwit, Democratic Republic of Congo: A Cross-sectional StudyJ Daniel Kelly, Nicole A Hoff, D'Andre Spencer, et al.
MMWR. Morbidity and Mortality Weekly Report|September 8, 2022
Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022Michel Tassetto, Miguel Garcia-Knight, Khamal Anglin, et al.
Ophthalmology Science|June 19, 2026
Pediatric Ebola Eye Disease in the PREVAIL (Partnership for Research on Ebola Virus in Liberia) III Longitudinal Cohort StudyRhea Kulkarni, Nii Quartey-Papafio, Jemma Larbelee, et al.
Plos Neglected Tropical Diseases|May 18, 2022
Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of CongoAnna Bratcher, Nicole A Hoff, Reena H Doshi, et al.
Epidemics|August 10, 2019
Real-time predictions of the 2018-2019 Ebola virus disease outbreak in the Democratic Republic of the Congo using Hawkes point process modelsJ Daniel Kelly, Junhyung Park, Ryan J Harrigan, et al.
The Journal of Infectious Diseases|January 12, 2018
Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16J Daniel Kelly, Mohamed Bailor Barrie, Annelies W Mesman, et al.
Plos Neglected Tropical Diseases|November 16, 2016
Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional SerosurveyEugene T Richardson, J Daniel Kelly, Mohamed Bailor Barrie, et al.
Plos Neglected Tropical Diseases|August 12, 2021
Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of CongoAnna Bratcher, Nicole A Hoff, Reena H Doshi, et al.
Pageof 14